BNET Industries
Last Fiscal Year Sales:$133.0K
- Public
- US
Dow Jones Description
We are an early-stage biotechnology company focused on the acquisition and development of novel technologies and products to address significant, unmet medical needs. Our strategy is to in-license and to develop products through human proof-of-concept studies (Phase I and II clinical trials of the U.S. Food and Drug Administration's regulatory process) prior to partnering with major pharmaceutical, biotechnology or healthcare product firms for advanced clinical development and commercialization. Our most advanced product, which we refer to as replacement therapy, is a one-time topical treatment to prevent tooth decay. The FDA has approved our Investigational New Drug application ("IND") for replacement therapy and we plan to begin Phase I trials in 2005. Since inception, we have funded a significant portion of our operations from the public and private sales of our securities. We have generated no significant revenues from operations during the last two years. All of our revenues have been from a sponsored research agreement and Small Business Innovation Research ("SBIR") grants which have expired. We have not generated revenues from sales of products.
President & CEO
Bruce Stein StanleyNumber of Employees 9
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
StockProfiler.US: Stock Profiler.US: Stock Watch: ORNI, PFAP, NHLD, SIAF
-
Oragenics Launches Teddys Pride Oral Care for Dogs and Cats
-
Oragenics Announces $5,000,000 in New Financing, and Changes in Its Board of Directors and Management
-
Oragenics Secures New Financing and Makes Changes to Its Board and Management
News & Analysis
Filter by
oragenics inc. - All News and Analysis
ONI, PPD, ACH, TASR, IVOW, IOTN Have Been Removed From Naked Short List Today.
M2 PRESSWIRE-8 December 2006-BUYINS.NET: ONI, PPD, ACH, TASR, IVOW, IOTN Have Been Removed From Naked Short List TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:08122006 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short...
DRRA, JSDA, MSO, ONI, ADGO, ETLSE Have Been Removed From Naked Short List Today.
M2 PRESSWIRE-31 August 2006-BUYINS.NET: DRRA, JSDA, MSO, ONI, ADGO, ETLSE Have Been Removed From Naked Short List TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:31082006 www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold...
CAB, DRRA, GGBM, HDTV, MOVI, ONI Have Been Added To Naked Short List Today.
M2 PRESSWIRE-22 August 2006-BUYINS.NET: CAB, DRRA, GGBM, HDTV, MOVI, ONI Have Been Added To Naked Short List TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:22082006 www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold...
GNLB, HOM, NFLX, NILE, ONI, WZEN Have Also Been Added To Naked Short List Today.
M2 PRESSWIRE-15 June 2006-BUYINS.NET: GNLB, HOM, NFLX, NILE, ONI, WZEN Have Also Been Added To Naked Short List TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:15062006 www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short...
EmergingMarketsllc.com: Emerging Equity Alerts.
M2 PRESSWIRE-7 June 2006-Emerging Markets Consulting, LLC.: EmergingMarketsllc.com: Emerging Equity AlertsC1994-2006 M2 COMMUNICATIONS LTD RDATE:07062006 Orlando, FL - Stocks gaining traction in yesterday's trading are Charys Holding Company, Inc., (OTC BB: CHYS), Ocwen Financial Corporation, (NASDAQ: OCN), SonicWALL, Inc., (NASDAQ:...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Bruce Stein Stanley | President & CEO |
| David B Hirsch | Acting President and Chief Executive Officer |
| Robert Zahradnik | President & CEO |
| Ronald P. Evens | CEO & President |
| Stanley B Stein | Interim President and Chief Executive Officer and Director |
| Dr Jeffrey Hillman | President |
| Brian John Bohunicky | Chief Financial Officer |
| Brian Mouatt | Th Chief Dental Officer for England |
| Dorothy J. Delfino | Chief Financial Officer |
| George T. Hawes | Oragenics, Inc. Director |
| Hari Parkash | Director for Its Center Dental Studies and Research |
| Howard K Kuramitsu | Professor at the State University of New York at Buffalo |
| Paul A Hassie | |
| Per-Erik J Saris | Professor |
| Kevin H Sills | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| David J. Gury | Chairman and Director |
| Christine L. Koski | Board of Directors |
| Derek G. Hennecke | Board of Directors |
| Lane Markham | Board of Directors |
| Marc K Siegel | Board of Directors |
| Richard T Welch | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | President & CEO | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Acting President and Chief Executive Officer | Current |
| Evoraplus | Chief Operating Officer, Chief Financial Officer | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Oragenics, Inc. | Chief Financial Officer and Chief Operating Officer | Former |
| Touche, Inc. | Manager | Former |
| California Inc | Manager | Former |
| Cottonwoodgroup.Com | Associate | Former |
| Drake University Law School | Jd | Former |
| Indiana University | BA In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | President & CEO | Current |
| Evoraplus | Executive Vice President for Business | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Massachusetts, Inc. | Chief Executive Officer | Former |
| Professional Dental Technologies, Inc. | General Manager | Former |
| Therapeutics Incorporated | General Manager | Former |
| Professional Dental Technologies, Inc. | Partner | Former |
| Therapeutics Incorporated | Partner | Former |
| Massachusetts, Inc. | Chairman of the Board of Directors | Former |
| Ivigene Corporation | Director | Former |
| The Pennsylvania State University | PhD In Physical Chemistry | Former |
| Boston University | PhD Degree | Former |
| Boston University | Bachelor of Science Degree In Chemistry | Former |
| The Pennsylvania State University | Bachelor of Science Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | CEO & President | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Interim President and Chief Executive Officer and Director | Current |
| Evoraplus | President | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Dresdner Bank AG | Head of the North American Corporate Finance | Former |
| Dresdner Bank | Head of the North American Corporate Finance | Former |
| Columbia University | J.D. | Former |
| Columbia University | B.A | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | President | Current |
| Evoraplus | Chief Scientific Officer | Current |
| Oragenics, Inc. | Founder | Former |
| Oragenics, Inc. | Chief Scientific Officer and Director | Current |
| Venture Fund Management, LLC | Board of Directors | Current |
| Oragenics, Inc. | Board of Directors | Current |
| University of Florida | Professor | Former |
| Harvard Medical School | PhD In Molecular Biology | Former |
| Harvard School of Dental Medicine | Dmd Degree (Cum Laude) | Former |
| University of Chicago | Undergraduate | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Chief Financial Officer | Current |
Dr. Brian Mouatt served as the 5 th Chief Dental Officer for England and had previously served as Chief Dental Officer for Zambia. He is the past Chair of the International Dental Federation s (FDI) World Dental Development Health Promotion Committee where he is spear heading the drive to improve oral health in the developing world. This committee is responsible for the management of the World Dental Development Fund. As recent President of the Commonwealth Dental Association (CDA), he revitalized the association and instituted programs of distant learning and virtual meetings.
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Th Chief Dental Officer for England | Current |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Chief Financial Officer | Current |
| University of Hawaii | Masters of Information Science | Former |
| University of Florida | Masters In Accounting | Former |
| Organization | Position | Status |
|---|---|---|
| Bioflorida, Inc. | Founder | Current |
| Oragenics, Inc. | Chairman and Director | Current |
| Geneex, Inc. | Chairman | Current |
| Nabi Biopharmaceuticals | Chairman | Current |
| Redchip Companies, Inc. | Director | Current |
| Assureimmune LLC | Board of Directors | Current |
| Bioflorida, Inc. | Board of Directors | Current |
| Science, The Charles E. Schmidt College | Board of Directors | Current |
| Bioheart, Inc. | Board of Directors | Current |
| Nabi Biopharmaceuticals | CEO | Former |
| NABI | President | Former |
| Nabi Biopharmaceuticals | President | Former |
| NABI | Chief Operating Officer | Former |
| Nabi Biopharmaceuticals | Chief Operating Officer | Former |
| Arthur Anderson & Co. | Intern | Former |
| University of Chicago | Research Fellow | Former |
| Bioflorida, Inc. | Chairman | Former |
| Juvenile Diabetes Foundation | Chairman | Former |
| Geneex, Inc. | Board of Directors | Former |
| Juvenile Diabetes Foundation | Director | Former |
| Oragenics, Inc. | Board of Directors | Former |
| University of Chicago | MBA | Former |
| Kenyon College | A.B. In Economics | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Oragenics, Inc. Director | Current |
| Proginet Corporation | Audit Committee Chairman | Current |
| Proginet Corporation | Board of Directors | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Gentry Resources Ltd. | Director | Current |
| Midway Gold Corporation | Board of Directors | Current |
| Gentry Resources, Ltd. | Former | |
| KPMG International | Former | |
| Avon Products, Inc. | Former | |
| Cranstoun | Former | |
| University of Notre Dame | Bba | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Director for Its Center Dental Studies and Research | Current |
| Organization | Position | Status |
|---|---|---|
| State University of New York at Buffalo | Ub Distinguished Professor | Current |
| Oragenics, Inc. | Professor at the State University of New York at Buffalo | Current |
| Immunity, Inc. | Board of Directors | Current |
| The Infection | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Current | |
| Piper Capital, LLC. | Current | |
| Bioflorida, Inc. | President | Former |
| Ernst & Young | Senior Manager | Former |
| Bryant University | MBA In Management | Former |
| Bryant University | Master of Science In Taxation | Former |
| Bryant University | BS Accounting | Former |
| American Institute of Certified Public Accountants | Certificate In Financial Forensics | Former |
Dr. Per-Erik J. Saris, Ph.D . is a professor in food microbiology at the University of Helsinki in Finland. He is an expert in antibacterial peptides produced by bacteria. His team is part of the Centre of Excellence Microbial Resources appointed by the Academy of Finland. He was the first to amplify DNA directly from bacteria in 1990 and has since been active in different fields of molecular biology of bacteria including vaccine development, protein production, metabolic engineering and targeting of bacteria.
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Professor | Current |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Board of Directors | Current |
Derek G. Hennecke. Mr. Hennecke, age 41, has served as a member of our board of directors since January 2008. Mr. Hennecke is an expert in drug development. He is a founder and CEO of Xcelience, a formulation and clinical manufacturing contract research company in Tampa, Florida. His management experiences over 25 years in the international biotechnology industry include: MDS Pharma Sciences, as Vice-president and General Manager for biopharmaceuticals, formulations, manufacturing, and pharmaceutics; DSM (contract manufacturing company) in active pharmaceutical ingredients, new business development (NBD) and manufacturing; and Biochemical Research Division of Boehringer Mannheim in NBD. His work included assignments in Europe, Egypt, Mexico, Canada, and USA. In these roles, he built the operations or businesses to introduce various drug products to Europe or the USA. During his career, Derek has worked in Germany and Canada for Roche s research activities. He earned a BS University of Alberta (Canada), and MBA, Erasmus University (Rotterdam, Netherlands).
| Organization | Position | Status |
|---|---|---|
| Xcelience, LLC | Chief Executive Officer & President | Current |
| Oragenics, Inc. | Board of Directors | Current |
| Xcelience, LLC | Board of Directors | Current |
| Xcelience, LLC | Founder | Former |
| Roche | Former | |
| Erasmus University | MBA | Former |
| University of Alberta | Bsc | Former |
| Xcelience, LLC | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Director | Current |
| The Center for Professional Advancement | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Board of Directors | Current |
Marc is Clinical Associate Professor of Medicine at NYU School of Medicine and Medical Director of Doctor Radio with NYU and Sirius Satellite Radio. Dr. Siegel is a Fox News Medical Contributor, a columnist for the Los Angeles Times, a member of the Board of Contributors at USA Today, a regular contributor to the NY Post, and a frequent contributor to the Washington Post, the Wall Street Journal, and Newsday. He is also the author of two non-fiction books, including False Alarm: the Truth about the Epidemic of Fear, a Discover Magazine top-twenty book of 2005.
| Organization | Position | Status |
|---|---|---|
| Fear, Inc. | Current | |
| Oragenics, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Oragenics, Inc. | Board of Directors | Current |
| Louisiana State University | Bsc In Management | Former |
| Oragenics, Inc. | Chairman | Former |
Executive News
-
Xcelience Expands Formulation Development and Quality Assurance
-
Company Profile for Xcelience, LLC
-
Oragenics Secures New Financing and Makes Changes to Its Board and Management
-
BioFlorida Announces New Awards Ceremony at 12th Annual Conference November 4 - 6, 2009 at the JW Marriott Orlando, Grande Lakes
-
BioFlorida Announces New Awards Ceremony at 12th Annual Conference November 4 - 6, 2009 at the...
-
BioFlorida Announces New Awards Ceremony at 12th Annual Conference November 4 " 6, 2009 at the JW Marriott Orlando, Grande Lakes
-
Oragenics Announces $5,000,000 in New Financing, and Changes in Its Board of Directors and...
-
Oragenics Announces $5,000,000 in New Financing, and Changes in Its Board of Directors and Management
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes


